Ovid Therapeutics Inc. (OVID) Reports Q2 EPS of $0.12
Tweet
Share
E-mailGet Alerts OVID Hot Sheet
Join SI Premium – FREE
Ovid Therapeutics Inc. (NASDAQ: OVID) reported Q2 EPS of $0.12, versus ($0.18) reported last year. Revenue for the quarter came in at $169 thousand, versus $75 thousand reported last year.
For earnings history and earnings-related data on Ovid Therapeutics Inc. (OVID) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Scottie Resources plans C$27M raise via dual private placements
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
